EP 3500583 A1 20190626 - PURE HEPTASULFATED DISACCHARIDES HAVING IMPROVED ORAL BIOAVAILABILITY
Title (en)
PURE HEPTASULFATED DISACCHARIDES HAVING IMPROVED ORAL BIOAVAILABILITY
Title (de)
REINE HEPTASULFATIERTE DISACCHARIDE MIT VERBESSERTER ORALER BIOVERFÜGBARKEIT
Title (fr)
DISACCHARIDES HEPTASULFATÉS PURS À BIODISPONIBILITÉ ORALE AMÉLIORÉE
Publication
Application
Priority
- US 201662375528 P 20160816
- US 2017046774 W 20170814
Abstract (en)
[origin: WO2018035050A1] Hypersulfated disaccharides with utility in asthma or asthma related disorders are disclosed. The heptasulfated disaccharides administered orally have comparable bioavailability to the intravenous administered dosage form.
IPC 8 full level
C07H 1/00 (2006.01); A61K 9/00 (2006.01); A61K 31/7024 (2006.01); A61P 11/00 (2006.01); A61P 11/06 (2006.01); A61P 29/00 (2006.01); C07H 11/00 (2006.01)
CPC (source: EP IL US)
A61K 9/0019 (2013.01 - EP IL US); A61K 9/0053 (2013.01 - IL US); A61K 9/007 (2013.01 - IL US); A61K 9/0073 (2013.01 - EP IL US); A61K 9/0095 (2013.01 - IL); A61K 31/7024 (2013.01 - EP IL US); A61P 37/08 (2018.01 - EP IL US); C07H 1/00 (2013.01 - EP IL US); C07H 11/00 (2013.01 - EP IL US); A61K 9/0095 (2013.01 - EP US); C07B 2200/13 (2013.01 - IL US)
Designated contracting state (EPC)
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated extension state (EPC)
BA ME
DOCDB simple family (publication)
WO 2018035050 A1 20180222; EP 3500583 A1 20190626; IL 264851 B 20211201; TW 201815394 A 20180501; US 10829509 B2 20201110; US 2019185503 A1 20190620; US 2021009620 A1 20210114
DOCDB simple family (application)
US 2017046774 W 20170814; EP 17757990 A 20170814; IL 26485119 A 20190214; TW 106127418 A 20170814; US 201716325940 A 20170814; US 202017028109 A 20200922